261 related articles for article (PubMed ID: 29603405)
1. Short- and long-term cost and utilization of health care resources in Parkinson's disease in the UK.
Weir S; Samnaliev M; Kuo TC; Tierney TS; Walleser Autiero S; Taylor RS; Schrag A
Mov Disord; 2018 Jul; 33(6):974-981. PubMed ID: 29603405
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal Healthcare Utilization and Costs in Parkinson's Disease: Pre-Diagnosis to 9 Years After.
Soh EML; Neo S; Saffari SE; Wong ASY; Ganesan G; Li W; Ng HL; Xu Z; Tay KY; Au WL; Tan KB; Tan LCS
J Parkinsons Dis; 2022; 12(3):957-966. PubMed ID: 34974439
[TBL] [Abstract][Full Text] [Related]
3. Burden of illness in Parkinson's disease.
Huse DM; Schulman K; Orsini L; Castelli-Haley J; Kennedy S; Lenhart G
Mov Disord; 2005 Nov; 20(11):1449-54. PubMed ID: 16007641
[TBL] [Abstract][Full Text] [Related]
4. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia.
Cordato DJ; Schwartz R; Abbott E; Saunders R; Morfis L
J Clin Neurosci; 2006 Jul; 13(6):655-8. PubMed ID: 16797991
[TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.
Holden SE; Morgan CL; Qiao Q; Jenkins-Jones S; Berni ER; Currie CJ
Diabetes Obes Metab; 2017 Aug; 19(8):1097-1105. PubMed ID: 28218819
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of Parkinson's disease in a developing country: a retrospective cost analysis in Shanghai, China.
Wang G; Cheng Q; Zheng R; Tan YY; Sun XK; Zhou HY; Ye XL; Wang Y; Wang Z; Sun BM; Chen SD
Mov Disord; 2006 Sep; 21(9):1439-43. PubMed ID: 16773620
[TBL] [Abstract][Full Text] [Related]
8. Drug and treatment costs in Parkinson's disease patients in Sweden.
Lökk J; Borg S; Svensson J; Persson U; Ljunggren G
Acta Neurol Scand; 2012 Feb; 125(2):142-7. PubMed ID: 21470194
[TBL] [Abstract][Full Text] [Related]
9. A discrete event simulation model to evaluate the use of community services in the treatment of patients with Parkinson's disease in the United Kingdom.
Lebcir R; Demir E; Ahmad R; Vasilakis C; Southern D
BMC Health Serv Res; 2017 Jan; 17(1):50. PubMed ID: 28100215
[TBL] [Abstract][Full Text] [Related]
10. The incidence and healthcare costs of persistent postoperative pain following lumbar spine surgery in the UK: a cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).
Weir S; Samnaliev M; Kuo TC; Ni Choitir C; Tierney TS; Cumming D; Bruce J; Manca A; Taylor RS; Eldabe S
BMJ Open; 2017 Sep; 7(9):e017585. PubMed ID: 28893756
[TBL] [Abstract][Full Text] [Related]
11. Direct costs and survival of medicare beneficiaries with early and advanced Parkinson's disease.
Kaltenboeck A; Johnson SJ; Davis MR; Birnbaum HG; Carroll CA; Tarrants ML; Siderowf AD
Parkinsonism Relat Disord; 2012 May; 18(4):321-6. PubMed ID: 22177623
[TBL] [Abstract][Full Text] [Related]
12. Reoperation following lumbar spinal surgery: costs and outcomes in a UK population cohort study using the Clinical Practice Research Datalink (CPRD) and Hospital Episode Statistics (HES).
Weir S; Kuo TC; Samnaliev M; Tierney TS; Manca A; Taylor RS; Bruce J; Eldabe S; Cumming D
Eur Spine J; 2019 Apr; 28(4):863-871. PubMed ID: 30701310
[TBL] [Abstract][Full Text] [Related]
13. Resource use and costs in a Swedish cohort of patients with Parkinson's disease.
Hagell P; Nordling S; Reimer J; Grabowski M; Persson U
Mov Disord; 2002 Nov; 17(6):1213-20. PubMed ID: 12465059
[TBL] [Abstract][Full Text] [Related]
14. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
[TBL] [Abstract][Full Text] [Related]
15. Comparing healthcare cost associated with the use of enzyme-inducing and non-enzyme active antiepileptic drugs in elderly patients with epilepsy in the UK: a long-term retrospective, matched cohort study.
Borghs S; Byram L; Chan J; Dedeken P; Logan J; Kiri V; Noack-Rink M; Patsalos PN; Thieffry S
BMC Neurol; 2020 Jan; 20(1):7. PubMed ID: 31914953
[TBL] [Abstract][Full Text] [Related]
16. [Cost of illness and health service patterns in Morbus Parkinson in Austria].
von Campenhausen S; Winter Y; Gasser J; Seppi K; Reese JP; Pfeiffer KP; Geiger-Gritsch S; Bötzel K; Siebert U; Oertel WH; Dodel R; Poewe W
Wien Klin Wochenschr; 2009; 121(17-18):574-82. PubMed ID: 19890747
[TBL] [Abstract][Full Text] [Related]
17. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
Maurel F; Lilliu H; Le Pen C
Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
[TBL] [Abstract][Full Text] [Related]
18. Economic Analysis of Deep Brain Stimulation in Parkinson Disease: Systematic Review of the Literature.
Becerra JE; Zorro O; Ruiz-Gaviria R; Castañeda-Cardona C; Otálora-Esteban M; Henao S; Navarrete S; Acevedo JC; Rosselli D
World Neurosurg; 2016 Sep; 93():44-9. PubMed ID: 27216925
[TBL] [Abstract][Full Text] [Related]
19. Incremental health care resource utilization and costs associated among patients with Parkinson's disease psychosis and incident dementia: An analysis of medicare beneficiaries.
Rajagopalan K; Rashid N; Gopal D; Doshi D
Int J Geriatr Psychiatry; 2023 Nov; 38(11):e6017. PubMed ID: 37936540
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
Findley LJ; Lees A; Apajasalo M; Pitkänen A; Turunen H
Curr Med Res Opin; 2005 Jul; 21(7):1005-14. PubMed ID: 16004667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
